Clinical Trial Update: Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis [NA]

View source ↗

Summary

A randomized study of folic acid therapy for hyperhomocysteinemia in patients with end-stage renal disease on hemodialysis has completed. This document provides…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperhomocysteinemia

Drugs mentioned

• folic acid (folic acid)

Snippet

Sponsor: Georgetown University | Conditions: End Stage Renal Disease, Hyperhomocysteinemia | NA | Status: COMPLETED